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Bipolar Disorder (BD) is a chronic mental disorder that occurs around 3% of the world's 
population and leads to increasing rates of cognitive and functional disability1 and 
mortality2. It is classified as an affective disorder with fluctuations in mood and behavior 
resulting in notable distress and affecting patient’s well-being.  
The ICD-10 defines two types of BD. BD includes episodes of depression and mania 
(Bipolar Disorder Type I) or episodes of depression and hypomania (Bipolar Disorder Type 
II), the latter being defined as moderate phases of mood elevation distinguished by 
duration and severity to full-blown mania.  While depressive episodes include negative 
mood, lack of energy and loss of interest, mania is characterized by elevated mood, 
restless psycho-motoric activity and impulsivity3.   
 
Disturbed Sleep in BD 
Alternations in sleep quality were not only identified during depressive or manic episodes. 
Meta-analysis of BD showed impairments in sleep latency, sleep duration, wake after sleep 
onset (WASO) and sleep efficiency4.  Additionally, sleep-wake variables showed a higher 
night-to-night variability during euthymic states5.    
Several datasets suggest that sleep impairment is not only a symptom of BD but an 
important factor contributing to the development of manic and hypomanic behavior itself. 
Experimental and longitudinal studies with patients, healthy subjects and animals showed 
that sleep deprivation lead to mood changes in the following days and that disrupted sleep 
caused more severe manic symptoms6-12. The other way round, cognitive behavioral 




efficiency resulted in a lower manic and hypomanic relapse13. 
Thus, sleep has an important role for BD in many aspects - as a symptom, a contributing 
part to the development of the disorder or therapeutical intervention. 
However, not only differed sleep itself is important. Excessive daytime sleepiness also plays 
an important role in BD. Daytime sleepiness without sufficient sleeping time has been 
descriped as an indicator for relapse to manic and hypomanic episodes in BD16.  
 
Arousal Model of Affective Disorders and Bipolar Disorder 
Daytime sleepiness has been characterized as the behavioral expression of an unstable 
CNS-arousal17. 
Arousal adapts to environmental stimulation and demands and is an individual condition 
from stable high arousal during an activated state (such as mental or physical effort) to 
unstable low arousal during a lower activation (such as mental and physical rest or even 
sleep). An EEG-based algorithm (Vigilance Algorithm Leipzig, VIGALL) allows objective 
measurement of arousal regulation18-20. 
The Arousal Regulation Model of Affective Disorders and Attention Deficit Hyperactivity 
Disorder (ADHD) suggests that unstable arousal in BD (and ADHD) can partly cause manic 
and hypomanic behavior. The initial situation of mania is seen in an unstable arousal 
caused by e.g. genetic disposition and sleep deficits. This triggers an autoregulatory 
behavioral syndrome with hyperactivity, sensation seeking and distractibility in order to 
stabilize the arousal, which leads to further sleep deficits and therefore even more unstable 
vigilance regulation. A vicious circle starts, finally resulting in full-blown mania21-24. 
 
If impaired sleep is seen both as a symptom and as a predisposing trait in BD, sleep 




episodes in patients already diagnosed with BD, but in individuals at high-risk of 
developing this mental disorder. Due to limitations of studying the sleep of BD patients in 
euthymic state, it remains unclear whether sleep impairments are a predisposition for 
manic and hypomanic states or whether they are merely a consequence of the disease 
process or due to medication since BD patients are often prescribed multiple medications 
impacting both arousal and sleep. 
 
Sleep in healthy Subjects with vulnerability for Bipolar Disorder 
Studying healthy subjects, who are vulnerable to BD, can improve our understanding of 
sleep impairment as a predisposing factor or as a mere symptom of BD. 
Genetic high-risk studies have shown that sleep in offspring of BD is also impaired by 
poorer sleep quality, irregularity of sleep-wake times and higher WASO25,26. The limitations 
of many genetic studies lie not only in small sample sizes but also in the exclusive focus on 
offspring of patients who have actually fallen ill with BD. 
The psychometric high-risk approach via questionnaires may be a useful step in order to 
overcome these limitations through larger sample sizes and less selection through 
focussing on subjects with parents with BD. 
 
Psychometric High-Risk Approaches 
The interest in psychometric high-risk approaches has a long tradition27 and remains high 
nowadays since such approaches offer promising contributions to the diagnostics of 
mental disorders. Adequate early intervention before the development of a full-blown 






Historical psychometric high-risk approaches were mainly focusing on psychosis. A 
longitudinal study showed that psychometric high-risk individuals for psychosis developed 
higher psychosis rates in the following 10 years28.  Relevant clinical symptoms were 
reported more often in psychometric high-risk individuals for psychosis as well29. Meta-
analysis of prognostic accuracy for psychometric high-risk individuals for psychosis showed 
a promising prognostic performance30 being encouraging for further psychometric high-risk 
research in other mental disorders as well. 
 
There have been several attempts for psychometric high-risk approaches for affective 
disorders as well. Typus Melancholicus was introduced to define a combination of traits 
consisting of being orderly and scrupulous and devoted to duty and family members31-35. 
This combination of traits was assumed to be a risk-factor for endogenous depression and 
a possible predictor for the development of depressive episodes36-38.   
 
The term Typus Manicus39, for example, was used as a description for a construct of certain 
personality traits of overactive and euphoric scope. Similar concepts are Hyperthymic 
Personality40 or  Hypomanic Personality41. The latter concepts has been proposed as a 
vulnerability for developing BD. 
 
Hypomanic Personality as a Vulnerability for Bipolar Disorder 
The Hypomanic Personality Scale (HPS) is a psychometric tool for identifying individuals at 
high risk for BD41. 
The HPS is a 48-item self-report questionnaire to detect hypomanic traits. Hypomanic 
Personality is a dimensional concept and is described as cheerful, equipped with a high 




extraverted and gregarious. At the same time, hypomanic attitude and behavior can be 
experienced as irresponsible, irritable, overbearing and reckless. Furthermore, subjects 
scoring high on HPS show a tendency to hypersexuality and drug use41. 
Similar phenomena can be found during manic and hypomanic episodes in BD. 
The Diagnostic and Statistical Manual of Mental Disorders describes these episodes as a 
temporary mood during a period of time, while otherwise the features of the Hypomanic 
Personality Scale are thought as outlasting through life and habitual trait. 
 
Several studies showed that people scoring high on HPS are vulnerable for developing BD, 
which could be acknowledged in later studies. While some authors describe Hypomanic 
Personality being associated with a higher risk for mainly manic episodes42-44, others show 
a higher risk for both depressive and manic episodes41,45. Most compelling is that the HPS 
predicted bipolar disorders in a 13-year follow-up study in so far not BD diagnosed 
subjects46. 
 
The HPS allows not only the identification of unusually high scorers at the end of the 
continuum, but also the assessment of the entire normal variance. Such dimensional 
assessments of psychopathology have recently attracted much interest in the context of the 
endophenotype approach47,48 and the Research Domain Criteria Project (RDoC) of the 
National Institute of Mental Health (NIMH)49. Certain phenomena such as sleep 
impairments can be described not only in categorcial assessments like an actual manic 
episode, but can occur in dimensional states as in euthymic BD or high-risk individuals as 






Hypomanic Personality and Sleep 
To date, only two small studies using student samples have assessed the association 
between sleep and the HPS using sleep diaries and actigraphy50,51. 
Shorter sleep duration was shown in HPS high scorers50,51. Also, greater night-to-night 
variability was observed in sleep duration and sleep efficiency50,51.   
A deeper understanding of objective and subjective sleep of Hypomanic Personality seems 
necessary. Sleep of HPS high scorers seems to fit the findings of disturbed sleep in manic, 
hypomanic and euthymic BD. As the HPS is a dimensional psychometric questionnaire, it 
seems interesting to not only focus on extreme groups such as HPS high-scorers and low-
scorers, who are already described in existing literature through the upper and lower decile 
of sum-scores, but to look at sleep alternations throughout the whole given results. 
 
As sleep impairment shows a relevant link to BD, it is important to find out if it is cause of 
the disease or a predisposing factor. This study analyzed the associations of objective and 
subjective sleep parameters and daytime sleepiness with individuals at psychometric high 
risk for BD, the hypomanic personality. The HPS seems to detect high-risk individuals as 
promising targets for early intervention in sleep improvement in order to improve 
dimensional symptoms and contributing trigger for manic and hypomanic episodes. 
To date, the findings in objective and subjective sleep of Hypomanic Personaltiy are limited 
and further investigations are needed.  
In a large cohort of healthy subjects, we expected associations between the HPS and 
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Vulnerability to bipolar disorder is linked to sleep
and sleepiness
Tilman Hensch 1,2, David Wozniak1, Janek Spada3, Christian Sander1,2,3, Christine Ulke 1,2,3, Dirk Alexander Wittekind1,
Joachim Thiery2,4, Markus Löffler2,5, Philippe Jawinski 2,3,6 and Ulrich Hegerl2,3,7
Abstract
Sleep impairments are a hallmark of acute bipolar disorder (BD) episodes and are present even in the euthymic state.
Studying healthy subjects who are vulnerable to BD can improve our understanding of whether sleep impairment is a
predisposing factor. Therefore, we investigated whether vulnerability to BD, dimensionally assessed by the hypomanic
personality scale (HPS), is associated with sleep disturbances in healthy subjects. We analyzed participants from a
population-based cohort who had completed the HPS and had either a 7-day actigraphy recording or a Pittsburgh
sleep quality index (PSQI) assessment. In addition, subjects had to be free of confounding diseases or medications. This
resulted in 771 subjects for actigraphy and 1766 for PSQI analyses. We found strong evidence that higher HPS scores
are associated with greater intraindividual sleep variability, more disturbed sleep and more daytime sleepiness. In
addition, factor analyses revealed that core hypomanic features were especially associated with self-reported sleep
impairments. Results support the assumption of disturbed sleep as a possibly predisposing factor for BD and suggest
sleep improvement as a potential early prevention target.
Introduction
Sleep disturbances and increased daytime sleepiness
occur in bipolar disorder (BD), including in the euthymic
state1,2. Accumulating evidence suggests that impaired or
reduced sleep and increased daytime sleepiness are not
only symptoms of BD, but contribute to the disease pro-
cess itself and to (hypo)manic behavior in particular.
Experimental and longitudinal studies of patients, healthy
subjects, and animals suggest that sleep deprivation can
induce (hypo)mania3–9. Accordingly, cognitive behavioral
therapy for inter-episode insomnia has resulted in a lower
(hypo)manic relapse rate10, and stabilization of sleep and
sleep–wake rhythms is an element of BD treatments11,12.
Further, in a recent study13 daytime sleepiness predicted
(hypo)manic relapse. Daytime sleepiness has been char-
acterized as the behavioral expression of an unstable
central nervous system (CNS)-arousal;14 and using elec-
troencephalogram (EEG), unstable arousal has been
demonstrated for BD, especially during mania15–18. The
arousal regulation model of affective disorders and
attention-deficit/hyperactivity disorder (ADHD)15,17 takes
into consideration this unstable arousal in BD (and
ADHD) and suggests that hypoarousal can partly cause
(hypo)manic behavior. In an autoregulatory manner, the
hyperactive and sensation-seeking behavior is seen as a
compensatory arousal-stabilizing behavior, which can in
turn increase sleep deficits, thus initiating a vicious circle
contributing to mania15,17,18.
If impaired sleep is in fact a predisposing trait for BD,
sleep improvement might be a target for early interven-
tions. However, present findings on impaired sleep in
euthymic BD leave it unclear to what extent these dis-
turbances are a predisposition, a consequence of the
disease process, or due to medication. For example, BD
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patients are often prescribed numerous medications19,
many of which impact both arousal and sleep. Studying
healthy subjects who are vulnerable to BD can improve
our understanding of whether sleep impairment is a
predisposing factor. Genetic high-risk studies have mostly
shown that sleep in healthy offspring of BD patients is
indeed impaired20–22. However, in addition to the small
sample sizes in many of these studies, a further inherent
limitation is the exclusive focus on a particular subgroup,
namely offspring of relatives who have fallen ill. There is
only one longitudinal study, which was not based on
genetic high-risk offspring but on a healthy community
sample, and which could nonetheless predict subsequent
development of BD during a ten year follow up by poor
sleep quality at baseline23. Moreover, this prediction of
BD by poor sleep persisted when excluding subjects with a
family history of affective disorders. However, results of
this study were based on only 20 subjects who developed a
full-blown BD. Missing data and a low probability of
incident BD in healthy subjects not genetically at-risk are
inherent problems of such longitudinal cohort studies.
Thus, more data are needed. The psychometric high-risk
approach24, which assesses BD risk in large populations
via questionnaires such as the hypomanic personality
scale (HPS)25, is one useful method. The HPS allows not
only the identification of unusually high scorers (high risk
subjects), but also the assessment of the total normal
variance. The association of the entire continuum of
bipolarity with sleep disturbances can then be examined.
Such dimensional concepts of psychopathology have
recently attracted much interest in the context of psy-
chiatric genetics and the endophenotype approach26–28,
and also the Research Domain Criteria Project (RDoC) of
the National Institute of Mental Health (NIMH) pointed
out the strength of dimensional assessments29.
The HPS assesses features of hypomanic episodes as
described within the diagnostic systems, but also includes
correlated traits such as social dominance. As the scale
assesses a temperamental dimension, i.e., a personality
trait rather than an acute episode, subjects are instructed
to respond how they feel in general. Several studies have
demonstrated the scale’s reliability and validity. The HPS
is stable over time25,30, has been associated with psy-
chiatric risk genes31,32, aggregates in families of afflicted
patients33 and has discriminated bipolar patients from
controls34,35. Cross-sectionally, HPS high scorers showed
higher rates of (hypo)manic and depressed episodes and
more psychosocial impairment and substance-use25,36,37.
Longitudinally, the HPS predicted BD and hypomanic
symptoms in addition to related disorders such as sub-
stance abuse38–40.
Further evidence for the role of hypomanic traits in BD
have been presented by other authors such as Hagop S.
Akiskal and Richard A. Depue41. Akiskal developed an
interview (TEMPS-I42) and self-rating instrument
(TEMPS-A43,44) in which the hyperthymic and cyclothy-
mic temperaments measure comparable constructs to the
HPS45,46. As is the case with the HPS, the TEMPS-A
temperaments show long-term stability47, aggregate in
families27,48, have been associated with psychiatric risk
genes49 and have been used to discriminate and predict
bipolar symptomatology48,50. One difference between the
TEMPS-A and the HPS is that the TEMPS-A assesses a
hyperthymic temperament separately from a cyclothymic
temperament, whereas in the HPS both aspects are
summed together in one total score. However, it has
recently been suggested that the HPS should be separated
into different subscales which may have divergent psy-
chopathological correlates51–53. In addition to the
research on affective temperament scales such as HPS and
TEMPS-A, longitudinal studies have contributed further
evidence that subthreshold hypomanic symptoms often
precede BD39,54–58.
To date, only two small studies using student samples
have assessed the association between sleep and HPS. In
HPS high-scorers, greater intraindividual variability in
sleep duration was observed via sleep diaries59 and acti-
graphy60. The latter study60 also showed shorter sleep
duration and greater intraindividual variability in sleep
efficiency in HPS high-scorers. As is usually the case,
these two studies utilized the HPS total sum-score.
However, in two recent studies51,53 HPS subscales were
derived from factor analyses which differed in their
associations with psychopathologically relevant
traits51,53,61.
Objectives
The current study analyses the associations of objec-
tive and subjective sleep parameters and daytime slee-
piness with a risk factor for BD, the HPS. In a large
cohort of healthy subjects, we expect associations
between the HPS and shorter and more disturbed sleep,
increased daytime sleepiness and more night-to-night
sleep-variability. In contrast to most prior research, we
not only associate sleep with the HPS total score, but
also with HPS subscales. To this end, we conducted the
first factor analysis on the German translation62 of the
HPS. We hypothesize that the associations of the HPS




The study sample was drawn from the LIFE-Adult
study63, a population-based cohort comprised of 10,000
inhabitants of the city of Leipzig, Germany. Of the total
sample, 3031 participants aged 60–82 years completed the
HPS. Subjects had to be free of diseases or medications
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which could strongly impact sleep–wake behavior. Thus,
participants with a history of stroke, multiple sclerosis,
Parkinson’s disease, epilepsy, skull fracture, cerebral
tumor, or meningitis were excluded, leaving 2788 sub-
jects. Further excluded were individuals reporting current
use of CNS-affecting drugs (leaving 2373 subjects). Based
on data from structured clinical interviews for DSM-IV
Axis I disorders, we selected subjects without a lifetime
history of substance dependence, psychotic or BDs, and
who were free of current affective or anxiety disorders
(leaving 2087 subjects). In addition, participants were
required to have available data from either the Pittsburgh
sleep quality index (PSQI) assessment or an actigraphy
recording for at least five nights. This resulted in a final
sample of 771 subjects for actigraphy association analyses
(372 female, Mage= 70.3 y), and 1766 subjects for PSQI
association analyses (835 female, Mage= 69.6 y). Factor
analyses of the HPS were conducted using all 2861 sub-
jects with complete HPS responses (1371 female; age
range: 60–82 years; Mage= 70.0). The study was approved
by Leipzig University’s Ethics Committee (263-2009-
14122009) and subjects gave written informed consent.
Objective and subjective sleep assessment
To obtain objective measurements of sleep, subjects
wore the SenseWear Pro 3 Armband actigraph (Body-
Media; Pittsburgh, Pennsylvania) for an average of
6.9 days (range: 5–7 days). Analyses of night-sleep para-
meters were carried out as described in detail else-
where64–66. Subjective ratings of sleep and sleep quality
were obtained using the German version of the PSQI67 a
self-rating instrument to assess sleep quality during the
past 4 weeks.
Hypomanic personality scale (HPS)
The HPS, a self-rating scale used to assess BD risk25,
was developed in undergraduates, which is reflected in
some of the 48 items. As the current study administered
the HPS to elderly subjects, four items from the German
translation62 were deleted for reasons of compliance (see
Supplementary Methods).
Statistical analysis
The factorial structure of the HPS was analyzed using
the function irt.fa of R package psych (version 1.7.8) as
described in Supplementary Methods. Remaining statis-
tical analyses were performed using SPSS 22 (IBM;
Armonk, New York). Associations between the sleep
variables and the HPS were conducted for both the HPS
total sum-score (HPS total) and factor scores for each
subscale. We conducted partial Spearman correlations
adjusting for sex and age. In order to confirm the results,
we additionally compared the top and bottom decile HPS
groups using Kruskal–Wallis tests.
Results
Factorial structure of the HPS
In the Supplementum, factor analysis results are
described in detail and compared to the available factor
solutions reported in two younger non-German sam-
ples51,68. Results revealed three factors (see Supplemen-
tary Figs. S1–S3), which were well in line with prior
studies (see Supplementary Table S1). We labeled the first
factor hypomanic core, as it was comprised of items with
clearly hypomanic content. Items loading high on the
second factor (social vitality) describe high self-con-
fidence, social dominance, and leadership. The third fac-
tor appears to reflect a characteristic that has previously
been recognized as “ordinariness”, as it describes balanced
and controlled people who consider themselves as average
persons68. Thus, we retained the term ordinariness.
Correlation analyses
Table 1 shows the Spearman correlations between the
sleep parameters and HPS total as well as the subscales’
factor scores hypomanic core, social vitality, and ordi-
nariness. In total, 46 out of 84 correlations reached the
level of significance, with 40 of them remaining significant
after multiple-test correction (see Supplementary Table
S2). Accordingly, the quantile–quantile plot suggests that
the distribution of observed p values considerably differs
from a p value distribution under the null hypothesis
(Fig. 1).
Objective sleep data
HPS total was significantly associated with shorter sleep
duration, a greater number of awakenings, more time
awake after sleep-onset (WASO) and lower sleep effi-
ciency. At the subscale level, these sleep variables were
also significantly associated in the same direction with
hypomanic core, with the exception of number of awa-
kenings, which narrowly missed the significance level.
Associations of social vitality were similar, but only
WASO and sleep efficiency reached significance. Ordi-
nariness, in contrast, was not correlated with any of these
actigraphic sleep variables.
HPS total was even more strongly associated with the
night-to-night variability of the sleep parameters than
with the means. HPS total, hypomanic core and social
vitality were all associated with greater intraindividual
variability in sleep-onset time, sleep duration, number of
awakenings, WASO and sleep efficiency. In contrast,
Ordinariness was associated with lower intraindividual
variability in the number of awakenings, WASO, and
sleep efficiency.
Subjective sleep data (PSQI)
HPS total correlated significantly with more daytime
sleepiness and lower sleep quality. Even stronger
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associations with PSQI-variables were found for hypo-
manic core, which was associated with a longer latency of
sleep-onset, shorter sleep duration, lower sleep efficiency,
more daytime sleepiness, and lower sleep quality. The
obtained correlation coefficients for hypomanic core were
significantly higher than those of the HPS total (Supple-
mentary Table S3), with the exception of daytime
sleepiness which did not significantly differ in its positive
associations with HPS total and hypomanic core.
In contrast to HPS total and hypomanic core, social
vitality, and ordinariness were associated with better
subjective sleep and accordingly, both scales’ correlation
coefficients differed significantly from HPS total and
hypomanic core (Table S3). Social vitality and
Table 1 Partial Spearman correlations between hypomanic personality and sleep–wake variables






rho p rho p rho p rho p
Actigraphy (n= 771)
Means
Sleep-onset latency 0.038 0.294 0.042 0.240 0.054 0.134 −0.035 0.329
Sleep-onset time −0.006 0.864 −0.035 0.329 0.025 0.497 0.061 0.089
Sleep-offset time −0.013 0.721 −0.041 0.252 0.007 0.851 0.056 0.118
Sleep duration −0.079 0.029* −0.072 0.046* −0.059 0.101 0.034 0.350
NWAK 0.078 0.030* 0.069 0.056 0.069 0.056 −0.011 0.757
WASO 0.103 0.004** 0.091 0.011* 0.080 0.027* −0.046 0.203
Sleep efficiency −0.106 0.003** −0.101 0.005** −0.086 0.017* 0.033 0.361
Night-to-night variability
Sleep-onset latency 0.019 0.594 −0.005 0.893 0.076 0.036* −0.026 0.470
Sleep-onset time 0.122 7E−4** 0.102 0.004** 0.113 0.002** 0.009 0.813
Sleep-offset time 0.110 0.002** 0.119 9E−4** 0.069 0.057 −0.062 0.087
Sleep duration 0.098 0.006** 0.092 0.011* 0.097 0.007** −0.003 0.931
NWAK 0.145 6E−5** 0.109 0.002** 0.152 2E−5** −0.092 0.011**
WASO 0.115 0.001** 0.116 0.001** 0.095 0.008** −0.109 0.002**
Sleep efficiency 0.106 0.003** 0.095 0.008** 0.103 0.004** −0.092 0.011**
PSQI (n= 1766)
Sleep-onset latencya 0.013 0.576 0.078 0.001** −0.080 8E−4** −0.098 4E−5**
Bedtimea,b 0.029 0.230 0.018 0.444 0.041 0.087 0.001 0.968
Get-up timea −0.022 0.348 −0.023 0.344 −0.020 0.413 −0.013 0.581
Sleep durationa −0.038 0.114 −0.095 7E−5** 0.027 0.261 0.081 6E−4**
Sleep efficiencyc 0.002 0.925 −0.065 0.006** 0.071 0.003** 0.091 1E−4**
Daytime sleepinessa 0.075 0.002** 0.088 2E−4** 0.052 0.028* −0.086 3E−4**
PSQI scored 0.063 0.008** 0.158 3E−11** −0.063 0.008** −0.165 3E−12**
Night-to-night variability is operationalized by intraindividual standard deviation (ISD) across a single subject’s multiple nights.
Note that hypomanic core, social vitality and ordinariness here refer to factor scores derived from factor analyses as described in the Methods of the Supplementum.
Results were additionally confirmed by analyses with traditional sum scores (see Supplementary Table S4).
Effects of sex and age were partialled out. NWAK number of awakenings, WASO wake after sleep-onset time
*p < 0.05
**p < 0.01
aBased on the respective Pittsburgh sleep quality index (PSQI) item
bTime subject goes to bed
cQuotient of sleep duration and time in bed with the latter calculated from bedtime and get-up time
dPSQI total score calculated according the manual from all PSQI components; higher PSQI scores mean worse sleep quality
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ordinariness were associated with shorter sleep-onset
latency, higher sleep efficiency, and better sleep quality. In
addition, ordinariness also correlated with longer sleep
duration and lower daytime sleepiness, while social
vitality resembled hypomanic core in terms of its asso-
ciation with more daytime sleepiness.
Additional analyses for confirmation of correlation results
Further analyses were carried out to confirm that results
were not dependent on the data-analytic method. First, all
correlation analyses were repeated with unweighted sum-
scores for each HPS subscale instead of factor scores,
which resulted in comparable, albeit, as expected, some-
what weaker associations (Supplementary Table S4).
Second, analyses were repeated using HPS decile extreme
groups. Results resembled those of the correlation ana-
lyses (Supplementary Table S5), including the finding that
the HPS groups differed more strongly concerning the
intraindividual night-to-night variability of the sleep
parameters than concerning the means. Figure 2 shows
boxplots of the intraindividual sleep variability of acti-
graphic variables stratified by HPS extreme groups (see
Supplementary Fig. S4 for boxplots of all sleep variables).
With exception of sleep-onset latency, intraindividual
variability for all variables was significantly higher in the
top HPS decile group compared with the bottom decile
group.
Discussion
The current study analyzed whether increased vulner-
ability to BD, as assessed by the HPS, is linked to more
disturbed sleep in healthy subjects. Correlation analyses
were conducted between objective as well as subjective
sleep parameters and HPS subscales and total scale.
Extreme group comparisons were also carried out to
confirm results.
The correlation analyses as well as the extreme group
comparisons revealed that a higher HPS total score is
associated with worse sleep, greater night-to-night sleep
variability and more daytime sleepiness. Thus, results
confirm findings of impaired sleep in genetic high risk
studies21.
Variability matters and HPS subscales differ in their sleep
associations
A noteworthy finding is that the HPS was more strongly
associated with the night-to-night variability than with the
mean sleep variables. In line with this, irregularity in
sleep/wake behavior has been reported for euthymic and
manic patients2,69 and subjects with genetically or psy-
chometrically operationalized heightened BD-
risk2,21,59,60,70,71. In addition, another study found that
greater sleep variability during euthymic state was asso-
ciated with increased mania and depression severity over
12 months5. Thus, our results are in accordance with the
role of social/circadian rhythm dysregulation in BD59,72.
Another finding is that the HPS subscales differed in
their associations with perceived sleep (PSQI). First, the
correlations of hypomanic core with sleep were sig-
nificantly higher than the correlations of HPS total with
sleep. Second, and in contrast to HPS total and hypo-
manic core, ordinariness, and social vitality showed
associations in the opposite direction (i.e., they were
associated with better perceived sleep). For ordinariness
this was expected given the content of the scale. However,
the association of social vitality with better perceived sleep
is noteworthy, because the subscale is not only positively
correlated with hypomanic core but also with objective
































Fig. 1 Permutation-based quantile–quantile plot showing that
the observed p values (blue circles) considerably differ from a
random distribution under the null hypothesis (solid diagonal
line). For the set of 84 observed p values (21 sleep variables × 4
personality scores), one million sets of 84 expected p values were
derived after data permutation. During data permutation, original
correlations within the domain of hypomanic personality variables
and the domain of sleep variables were preserved while original
correlations between the two domains were removed through
random shuffling. Each set of p values was sorted in descending order.
The solid diagonal line represents the mean expected p values at rank
1–84 plotted against themselves. The upper and lower bound of the
gray area represent the 5th and 95th percentile of expected p values
plotted against the mean expected p values. The blue circles represent
the observed p values plotted against the mean expected p values
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positively correlated HPS facets are in line with the two
available studies51,53 in which factor-analytic derived HPS
subscales showed opposing associations with psycho-
pathologically relevant traits. It might be that subjects
scoring high on hypomanic core suffer more from
impaired sleep, as the first factor (corresponding to
hypomanic core in our analyses) has been found to be
positively related to neuroticism51, whereas subjects
scoring high on social vitality might not feel as impaired,
given a negative association of social vitality with neuro-
ticism51. Such reversed associations with HPS subscales
could cancel each other out in predicting sleep when
aggregated in the HPS total sum-score (as we demon-
strated in a post-hoc linear regression analysis in Sup-
plementary Results). Thus, the current study strongly
supports the suggestion, recently made by several authors,
of utilizing HPS subscales51–53,61.
In line with the findings of impaired objective sleep in
both, hypomanic core and social vitality, both subscales
were associated with increased daytime sleepiness. How-
ever, this increased sleepiness seems only to help subjects
scoring high on social vitality (presumably low in neu-
roticism) to quickly fall asleep, as was seen in the negative
correlation of social vitality with sleep-onset latency,
whereas hypomanic core was associated with longer sleep-
onset latency. Thus, hypomanic core more strongly
resembles long sleep-onset latencies in (euthymic) BD1,2
and ADHD73,74, which may, despite high sleepiness, occur
due to being too hyper and reluctant to fall asleep,
rumination, or circadian alterations.
Sleep duration and daytime sleepiness
The finding that HPS total and hypomanic core were
associated with shorter sleep duration is in line with studies
on naturally short sleepers who showed more hypomanic,
extraverted and impulsive traits75,76. The finding is also
consistent with one small study on young HPS high-scorers
and a study on children at genetic risk for BD. In both
studies, shorter sleep duration was also reported60,77. These
findings of shorter sleep contrast with the meta-analyses
reporting longer sleep in euthymic BD compared to normal
controls1,2. This might imply that long sleep duration is not
a preexisting factor but occurs later as part of the disease.
In addition, longer sleep could be merely a consequence of
the disease, as patients might spend more time in bed13 as a
consequence of sedating medications, unemployment or
the instruction to get adequate sleep in order to avoid
mania recurrence. Finally, the meta-analyses’ findings of
longer sleep during euthymia when measured with acti-
graphy should be considered with caution, as sleep diaries
did not show longer sleep but only longer time-in-bed2. It is
known that actigraphs based on accelerometers tend to
overestimate sleep duration in cases of insomnia sympto-
matology78. This might have contributed to the meta-
analyses’ findings of longer sleep (as assessed by actigraphy)
in euthymic BD compared to healthy controls. One can
speculate that in the current study, because the applied
SenseWear Armband uses not only an accelerometer, but
also temperature and galvanic skin response sensors to
estimate sleep, any potential overestimation of sleep dura-

































































































































Fig. 2 Boxplots of intraindividual night-to-night variability of actigraphic sleep variables stratified by HPS extreme groups. Intraindividual
night-to-night variability is operationalized by intraindividual standard deviation (ISD) across a single subject’s multiple nights. Boxplots are stratified
by top and bottom decile hypomanic personality scale (HPS) groups (HPS+, N= 63 vs. HPS−, N= 61). Boxes represent the interquartile range of
each distribution (data between the lower and upper quartile), with the horizontal line corresponding to the median. Whiskers extend to the furthest
observation within 1.5 times the interquartile range from the lower and upper quartile. Dots represent single data points, jittered horizontally to avoid
overplotting
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The current study found that greater daytime sleepiness
associates with HPS, which is in line with findings of
higher sleepiness scores in euthymic BD patients2. It has
been hypothesized that this sleepiness in BD reflects a
trait-like arousal instability in some BD patients15,16,
which would explain the impaired sustained attention in
the euthymic state and unaffected relatives79. In addition,
it has been speculated that the questionable efficacy and
mania-inducing properties of antidepressants in BD might
partly be attributable to their arousal-reducing properties,
which could be problematic if habitual arousal is already
low15,80,81. One might argue that increased sleepiness
should result in longer sleep duration. However, it has
been shown that in BD, longer sleep time and daytime
sleepiness are independent presentations of hypersom-
nia13,82. Thus, the current findings agree with the
assumption that hypoarousal plays a clinically relevant
role in BD.
The association of HPS with shorter sleep and greater
daytime sleepiness is in line with the arousal regulation
model of affective disorders and ADHD, which posits that
arousal instability due to short sleep or other reasons can
contribute to (hypo)mania and ADHD15,17,83. As EEG is
an excellent tool to assess arousal84, we have developed
and validated the publically available Vigilance-
Algorithm-Leipzig (VIGALL)14,85–89, which allows the
assessment of brain arousal in resting-EEG recordings.
Utilizing VIGALL, we demonstrated lower arousal during
(hypo)mania18, and in genetic studies we demonstrated
for the first time a link between arousal and ion chan-
nels90,91, which are of high relevance for BD92. ADHD
shows symptom overlap with mania and high comorbidity
with BD16,83. Correspondingly, several studies have also
shown both impaired sleep and hypoarousal in ADHD,
which may partly explain attention deficits, response to
stimulants and compensatory hyperactive behavior15,83,93.
As in mania, all factors which destabilize arousal such as
sleep deficits worsen ADHD symptomatology, whereas
sleep improvement is of therapeutic value15,17,83.
Prediction of HPS by sleep and covariates
For several reasons, our analyses focused only on sleep
variables. Thus, we did not include variables on the
diverse causes of disturbed sleep such as sleep apnea. One
practical reason for this was that the LIFE cohort com-
prises only limited data on the causes of disturbed sleep.
In fact, only two PSQI items provided information con-
cerning sleep apnea and periodic limb movement disorder
(with these two items not aggregated into the PSQI total
score). Thus, systematically accounting for sleep disorders
can only be done on a relatively weak basis. Most of all, we
focused on sleep variables because disturbed sleep has
been suggested as the final common pathway for a variety
of triggers for manic episodes9. Sleep disturbances for a
variety of reasons (e.g., life events, traveling, leisure
activities, circadian dysregulation, drugs, sleep apnea, or
periodic limb movement disorder) have been suggested to
contribute to (hypo)mania12. Finally, we focused our
analyses on sleep variables because our goal was to
facilitate comparisons of our results for each given sleep
variable, such as the WASO, with those from the available
literature, particularly the meta-analyses of euthymic
BD1,2.
Nonetheless, one might ask whether new insights would
arise when all variables, including socioeconomic status,
age, sex, and body mass index are included simultaneously
in multivariable analyses. To investigate the relative
importance of objective and subjective sleep variables
while accounting for other covariates in predicting HPS
scores, we carried out a series of regression analyses. In
order to avoid overfitting and inflated R2 estimates, we
pursued a tenfold cross-validation approach which
involves evaluating the performance of a prediction model
by applying the model to new data not used in training it.
Results, which are outlined in the Supplemental in more
detail, showed clear incremental predictive value of the
sleep variables over the covariates in predicting HPS total,
hypomanic core, and ordinariness (Supplementary Table
S6). The incremental value of the sleep variables was most
pronounced for hypomanic core, which is in line with
hypomanic core being most strongly correlated with sleep
in the correlation analyses. In contrast, there was no
incremental predictive value of sleep variables on HPS
social vitality. This finding could be due to the fact that a
large proportion of variance in HPS social vitality was
already explained by the covariate “socioeconomic status”
(see Supplementary Fig. S5), which might be considered
as further evidence that social vitalitymay be the healthier
facet of the HPS51
Strengths and limitations
The HPS has mostly been utilized in samples of ado-
lescents and young adults. To increase the appropriate-
ness of the HPS in our elderly subjects, we deleted four
items, thus limiting the comparability of our findings with
other studies. However, the factorial structure of the
shortened HPS in our sample of German elderly adults
largely overlapped with those derived from the total HPS
scale in younger samples51,53,68, suggesting that the uti-
lized version reveals comparable construct estimates even
across different national and age cohorts. Nonetheless,
our HPS subscales and their differential associations with
sleep variables need replication in other, particularly
younger samples. Concerning our subscales’ differential
association with BD, we are currently lacking data, but
would hypothesize hypomanic core to be most strongly
associated with BD. There is a large overlap of items from
our hypomanic core subscale with the items showing the
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largest correlations with BD diagnoses in a study by Miller
et al.34. All items from an HPS short version, comprising
the six items with the highest BD-association34, are part of
our hypomanic core subscale.
The current study demonstrated that the HPS is also
applicable in subjects older than 60 years, which is not
trivial given the strong decline of HPS scores with
increasing age. For example, in our PSQI sample the mean
of the HPS total score was M= 9.10 (SD= 5.37; mean
extrapolated to a scale length of 48 items). The means and
variances of younger samples are substantially higher. In the
undergraduate sample by Eckblad and Chapman25, the
mean was M= 21.74 (SD= 8.16). Similarly, in a German
sample62 with an age range of 17–30 years, the mean was
M= 18 (SD= 8.91). Thus, the current results are compel-
ling in light of the low HPS variance in our sample, which
may have made it more difficult to detect associations.
From another perspective, the older age of our sample
may be both a limitation and a strength. The aim of our
study was to associate the vulnerability factor HPS with
sleep, and we were not interested in associations due to
effects of current or former affective episodes or treat-
ments. Therefore, we excluded subjects with acute affec-
tive episodes, psychotropic drugs, or a life time diagnosis
of BD. In addition, our subjects are, due to their age,
relatively unlikely to develop BD in the future. This means
that, in contrast to studies in younger samples, we can
also be quite sure that prodromes of emerging episodes
have not biased our results. However, the age and
exclusion criteria of the current sample imply that we may
have analyzed a sample with superior health, not com-
parable to the younger samples in which the HPS has
mostly been used. Notwithstanding, from a dimensional
perspective on psychopathology, it is still reasonable to
associate the entire “remaining” vulnerability factor var-
iance with sleep. In addition, such a sample with superior
health will still include subjects at high risk for BD. These
subjects remained healthy, likely because of a lack of
triggering factors or life-events or because of additional
protective traits. It is remarkable that in this sample of
likely superior health, the HPS is still associated with
more impaired sleep and greater sleepiness.
The present study was well-powered and revealed
strong evidence for a link between hypomanic tempera-
ment and sleep alterations. Nevertheless, observed effect
sizes, albeit substantial in extreme group comparisons,
were small in correlation analyses across all subjects. One
reason for this might be that elderly subjects show low
variances in HPS and wake–sleep behavior. Further,
during the 7-day actigraphy assessment, sleep was
undoubtedly influenced by numerous factors beyond the
subject’s predisposition (e.g., common cold, sleep of the
partner, and reactivity to the actigraph). Given these
sources of error variance, the highly consistent results are
very compelling.
Conclusions
The associations of the HPS with worse sleep were
consistent, irrespective of the assessment modality and
data analysis method. Sleep inter-night variability showed
the most pronounced associations with HPS, thus further
qualifying as a characteristic variable in BD21,70,94,95. As a
further practical implication, this study supports the
suggestion recently made by other authors51–53 that using
HPS subscales will increase the diagnostic power.
The association of sleep alterations with HPS supports
assumptions derived from prior studies that sleep dis-
turbances may be a predisposing factor for BD. Analogous
to prior studies in which sleep difficulties predicted mood
episodes in genetic high risk off-spring70,77,96, one can
hypothesize that sleep might predict conversion to BD in
psychometric high-risk groups as assessed by the HPS.
Early interventions to prevent psychiatric disorders or
change their course are a cutting-edge topic in psy-
chiatry57. Thus, improving sleep in HPS high-scorers may
be a valuable early prevention approach, with sleep
symptoms being easy to assess, modifiable, and largely
free of social stigmatization.
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Hypomanic Personality Scale (HPS) 
We administered the German translation1 of the Hypomanic Personality Scale (HPS)2. The HPS is a self-rating 
instrument and is comprised of 48 dichotomous items. As the current study utilized the HPS in elderly subjects 
aged above 60 years for the first time, the following four inadequate items were deleted for reasons of 
tolerance and compliance: “I am frequently so ‘hyper’ that my friends kiddingly ask me what drug I’m 
taking”, “I expect that someday I will succeed in several different professions”, “There are so many fields I 
could succeed in that it seems a shame to have to pick”, “A hundred years after I’m dead, my achievements 
will probably have been forgotten”. 
Our HPS total sum score, with a possible maximum of 44, ranged from 0 to 37 (mean: 8.34, SD: 5.37) in 
the PSQI sample and from 0 to 37 (mean: 8.55, SD: 5.59) in the actigraphy sample. Extrapolated to a scale 
comprised of 48 items, the means were M = 9.10 and M = 9.33, respectively. 
 
 
HPS factor analysis  
Factor analyses were conducted using all 2,861 subjects with complete HPS responses (1371 female; age 
range: 60-82 years; mean age: 70.0). 
Given the dichotomous nature of the HPS items, a tetrachoric correlation matrix was performed first. 
Subsequently, minimum residual factoring was carried out followed by promax rotation. The number of 
factors was determined by scree plot inspection, the Very Simple Structure (VSS) criterion for complexity one 
and two, and Velicer’s Minimum Average Partial (MAP) criterion. We also assessed the congruency of the 
factor solution with results of a hierarchical cluster analysis that was carried out with the ICLUST function of 
the R package psych3. Factor scores were calculated using the function score.irt.2, which uses the two 
parameter Item Response Theory (IRT) equivalent of loadings and difficulties. Factor score calculations were 








Factorial structure of the HPS 
The scree test suggested a three-factor solution (Fig. S1). The other criteria indicated a one- (VSS for 
complexity one), three- (VSS for complexity two), and five-factor solution (Velicer MAP). 
Supplementary Fig. S1. Scree plot showing the eigenvalues of the principal factors derived from the 
tetrachoric correlation matrix of HPS items 
 
Eigenvalues are based on minimum residual factoring. Note that the eigenvalues of the 3-factor solution do not perfectly 




The hierarchical cluster analysis stopped combinations at three clusters (see Figure S2). As we achieved the 
highest agreement across the abovementioned indices with the three-factor structure, we decided to proceed 
with the three-factor model. The sums of squared loadings for the three factors derived from the minimum 
residual factor analysis were 9.87, 3.14, and 2.47. Following promax rotation, the sums of squared loadings 
were 7.62, 5.27, and 2.58, accounting for 35% of the variance observed in the 44 items. 
Figure S3 shows the correlation matrix of the HPS-items which were derived from the factor analysis. Factors 
one and two were correlated (0.45), while factor three was largely independent from factors one (0.06) and 
two (-0.05). The congruency of the factor-cluster solution was high, particularly regarding the first factor (.93), 









Supplementary Fig. S2. iCLUST output based on the tetrachoric correlation matrix of HPS items 
 
The two criteria for cluster combinations were as follows: (a) for two clusters of three or more items, combine only if the resulting cluster 
increases alpha past the maximum of the two subclusters, and (b) for two clusters of four items or more, combine only if the resulting 
cluster increases beta beyond the maximum of the two. Colored boxes indicate the congruency with factor analysis results, that is, colors 





Supplementary Fig. S3. Tetrachoric correlation matrix of the HPS items 
  




Supplementary Table S1 shows the loadings and IRT parameters of the HPS three-factor model and 
compares it to the factor solutions reported in two younger non-German samples by Rawlings et al.4 and 
Schalet et al.5  
The first factor comprises items with clear hypomanic content and largely overlaps with the factor ‘moodiness’ 
by Rawlings et al.4 and the factors ‘mood volatility’ and ‘excitement’ by Schalet and colleagues5. Note that 
the term ‘mood volatility’ has been criticized as only very few items actually ask for the lability of subjects’ 
mood. Terrien et al.6 therefore named the first factor in their confirmatory factor analysis ‘hypomanic mood’. 
However, because the first factor also comprises cognitive and energetic aspects, we use the term Hypomanic 
Core.  
Items loading high on the second factor describe high self-confidence, social dominance and leadership. 
This second factor largely overlaps with those previously labelled as ‘hypersociability’ and ‘social vitality’. In 
our study, we use the latter term, Social Vitality.  
The third factor appears to reflect a characteristic that has previously been recognized as ‘ordinariness’, as it 
describes balanced and controlled people who describe themselves as average persons.4 Thus, we retain the 
term Ordinariness. 
The factor score calculations for Hypomanic Core, Social Vitality and Ordinariness were based on those 











    
Item 
 
HYP SOC ORD 
 
HYP SOC ORD 
 
HYP SOC ORD 
 
Rawlings et al. 2000 Schalet et al. 2011 Item text 
05  0.479 0.126 0.047  0.545 0.127 0.047  0.068 0.061 0.060  Cognitive Mood Volatility Sometimes ideas and insights come to me so fast that I cannot express them all. 
07  0.408 0.227 -0.053  0.447 0.233 -0.053  0.954 0.894 0.872  excluded Social Vitality In unfamiliar surroundings, I am often so assertive and sociable that I surprise myself . . .  
08  0.644 -0.196 -0.172  0.843 -0.200 -0.174  0.719 0.561 0.558  Moodiness Mood Volatility There are often times when I am so restless that it is impossible for me to sit still. 
10  0.485 0.128 0.160  0.555 0.130 0.162  0.111 0.098 0.098  Moodiness Mood Volatility When I feel an emotion, I usually feel it with extreme intensity. 
11  0.569 -0.009 -0.022  0.692 -0.009 -0.022  1.045 0.860 0.860  Moodiness Excitement I am frequently in such high spirits that I can’t concentrate on any one thing for too . . .  
15  0.522 0.015 0.106  0.612 0.015 0.107  0.932 0.795 0.800  Moodiness Excitement I often feel excited and happy for no apparent reason. 
18  0.386 0.279 0.045  0.418 0.291 0.045  1.170 1.124 1.081  Moodiness Excitement I often have moods where I feel so energetic and optimistic that I feel I could . . .  
19  0.343 0.229 0.042  0.365 0.235 0.042  0.495 0.478 0.466  Cognitive Social Vitality I have such a wide range of interests that I often don’t know what to do next. 
20  0.496 0.194 -0.034  0.571 0.198 -0.034  1.581 1.399 1.373  Moodiness Mood Volatility There have often been times when I had such an excess of energy that I felt little . . .  
22  0.697 0.066 0.057  0.972 0.066 0.058  0.953 0.685 0.685  Moodiness Mood Volatility I very frequently get into moods where I wish I could be everywhere and do everything . . . 
33  0.620 0.125 0.005  0.789 0.126 0.005  1.704 1.348 1.338  Moodiness Excitement I often get so happy and energetic that I am almost giddy. 
35  0.548 -0.010 -0.120  0.654 -0.010 -0.121  1.257 1.052 1.059  Moodiness Mood Volatility I often get into moods where I feel like many of the rules of life don’t apply to me. 
38  0.792 -0.202 -0.137  1.297 -0.207 -0.139  0.968 0.604 0.597  Moodiness Mood Volatility I frequently find that my thoughts are racing. 
39  0.333 0.281 0.039  0.353 0.293 0.039  1.189 1.168 1.122  excluded Social Vitality I am so good at controlling others that it sometimes scares me. 
41  0.400 0.159 0.193  0.437 0.161 0.197  0.269 0.250 0.251  Cognitive Mood Volatility I do most of my best work during brief periods of intense inspiration. 
43  0.370 0.153 0.125  0.398 0.155 0.126  0.465 0.437 0.436  Cognitive Mood Volatility I have often been so excited about an involving project that I didn’t care about eating . . .  
45  0.763 -0.177 -0.168  1.182 -0.179 -0.170  1.546 1.014 1.013  Moodiness Mood Volatility I have often felt happy and irritable at the same time. 
46  0.704 -0.118 -0.114  0.992 -0.118 -0.115  1.992 1.424 1.424  Moodiness Excitement I often get into excited moods where it’s almost impossible for me to stop talking. 
44  0.828 -0.258 -0.293  1.476 -0.267 -0.307  1.851 1.074 1.086  Moodiness Mood Volatility I frequently get into moods where I feel very speeded-up and irritable. 
37  0.747 -0.262 -0.318  1.123 -0.272 -0.335  1.038 0.715 0.728  Moodiness Mood Volatility I seem to be a person whose mood goes up and down easily. 
32  0.445 0.312 -0.415  0.496 0.328 -0.456  1.789 1.686 1.761  Hypersociability Excitement I am considered to be kind of a “hyper” person. 
09  0.334 0.374 -0.162  0.355 0.403 -0.164  0.996 1.012 0.951  excluded Mood Volatility Many people consider me to be amusing but kind of eccentric. 
02  0.135 -0.535 0.113  0.137 -0.633 0.114  -0.955 -1.120 -0.953  Hypersociability Social Vitality It would make me nervous to play the clown in front of other people. 
04  0.029 0.570 0.019  0.029 0.693 0.019  1.706 2.075 1.706  Hypersociability Social Vitality I think I would make a good nightclub comedian. 
06  0.093 -0.456 0.192  0.094 -0.513 0.196  -0.657 -0.735 -0.666  Hypersociability Social Vitality When with groups of people, I usually prefer to let someone else be the center . . .  
13  0.104 0.496 0.265  0.105 0.572 0.275  -0.068 -0.078 -0.070  Cognitive Social Vitality People often come to me when they need a clever idea. 
25  0.182 -0.524 0.039  0.185 -0.615 0.039  -0.731 -0.843 -0.719  Hypersociability Social Vitality When I go to a gathering where I don’t know anyone, it usually takes me a while . . .  
26  0.042 0.574 -0.049  0.042 0.702 -0.049  0.954 1.165 0.954  excluded Social Vitality I think I would make a good actor, because I can play many roles convincingly. 
28  0.193 0.293 0.017  0.196 0.306 0.017  1.155 1.185 1.133  Cognitive Excluded I frequently write down the thoughts and insights that come to me when I am thinking . . .  
29  0.244 0.469 0.031  0.252 0.531 0.031  1.196 1.313 1.161  Hypersociability Social Vitality I have often persuaded groups of friends to do something really adventurous or crazy. 
30  0.005 0.515 -0.027  0.005 0.601 -0.027  1.282 1.495 1.282  excluded Social Vitality I would really enjoy being a politician and hitting the campaign trail. 
36  0.073 0.652 0.120  0.073 0.859 0.120  0.518 0.681 0.520  excluded Social Vitality I find it easy to get others to become sexually interested in me.a 
40  0.181 0.573 0.056  0.184 0.699 0.056  1.181 1.417 1.164  Hypersociability Social Vitality At social gatherings, I am usually the “life of the party.” 
42  0.218 0.621 0.086  0.224 0.793 0.086  0.990 1.232 0.969  Cognitive Social Vitality I seem to have an uncommon ability to persuade and inspire others. 
01  0.218 -0.644 0.307  0.224 -0.842 0.323  -1.516 -1.934 -1.554  Ordinariness Social Vitality I consider myself to be pretty much an average kind of person. 
14  0.079 -0.319 0.330  0.080 -0.337 0.349  -0.973 -1.024 -1.027  Ordinariness Social Vitality I am no more self-aware than the majority of people. 
27  0.123 -0.442 0.517  0.124 -0.492 0.605  -2.003 -2.216 -2.323  Ordinariness Social Vitality I like to have others think of me as a normal kind of person. 
12  0.218 0.164 0.317  0.223 0.166 0.334  -0.383 -0.379 -0.394  Cognitive Excluded I sometimes have felt that nothing can happen to me until I do what I am meant to . . .  
21  -0.180 -0.107 0.559  -0.184 -0.108 0.674  -1.243 -1.229 -1.474  Moodiness Mood Volatility My moods do not seem to fluctuate any more than most people’s do. 
24  -0.057 0.154 0.377  -0.057 0.155 0.407  -1.577 -1.594 -1.700  Moodiness Excluded When I feel very excited and happy, I almost always know the reason why. 
31  -0.126 0.030 0.465  -0.127 0.030 0.526  -2.023 -2.008 -2.267  Moodiness Mood Volatility I can usually slow myself down when I want to. 
17  -0.314 0.100 0.709  -0.330 0.101 1.006  -1.609 -1.536 -2.168  excluded Excitement I am usually in an average sort of mood, not too high and not too low. 
16  -0.050 -0.156 0.241  -0.050 -0.158 0.248  -0.431 -0.436 -0.443  Ordinariness Social Vitality I can’t imagine that anyone would ever write a book about my life. 
47  0.181 -0.228 0.268  0.184 -0.234 0.278  -0.891 -0.900 -0.909  Ordinariness Social Vitality I would rather be an ordinary success in life than a spectacular failure. 
HPS: Hypomanic Personality Scale (Eckblad & Chapman, 1986), IRT: Item response theory, HYP: HPS facet ‘hypomanic core‘, SOC: HPS facet ‘social vitality’, ORD: HPS facet ‘ordinariness’, a No sexual content in 
the German translation1 of the item. Minimum residual factor analysis was based on tetrachoric correlations. Loadings and IRT discrimination parameters are bold where they are higher than or equal to the cut-off 
value 0.300. IRT difficulty parameters are bold where the corresponding IRT discrimination parameters are higher than or equal to the cut-off value 0.300. Note that subsequent factor score calculations were based 





Extending from meta-analyses’ findings showing various forms of sleep impairment in euthymic BD7,8, the 
current study examined the association of individual sleep variables with the HPS, a psychometric risk factor 
for BD. Because each test was hypothesis-driven, there was no need for multiple-testing correction9,10. 
However, to confirm that results persisted after correction for multiple testing, we additionally calculated the 
False Discovery Rate (FDR)-corrected p values according to Benjamini-Hochberg11 and regarded 
associations with FDR < 0.05 as significant after multiple testing correction. In total, 40 out of the 46 
nominal significant correlations remained significant after multiple-testing correction (see Table S2). 
 
Supplementary Table S2. Partial Spearman correlations between HPS and sleep-wake variables. FDR-
corrected and nominal p-values are given for comparison  







 HPS subscale 
Ordinariness 
 rho p FDR rho p FDR rho p FDR rho p FDR
Actigraphy (n = 771)     
Means     
Sleep-onset latency .038 .294 .399 .042 .240 .342 .054 .134 .200 -.035 .329 .432 
Sleep-onset time -.006 .864 .907 -.035 .329 .432 .025 .497 .580 .061 .089 .144 
Sleep-offset time -.013 .721 .797 -.041 .252 .353 .007 .851 .905 .056 .118 .180 
Sleep duration -.079 .029 .057* -.072 .046 .084* -.059 .101 .160 .034 .350 .439 
NWAK .078 .030 .058* .069 .056 .098 .069 .056 .098 -.011 .757 .826 
WASO .103 .004 .014** .091 .011 .025** .080 .027 .055* -.046 .203 .299 
Sleep efficiency -.106 .003 .011** -.101 .005 .016** -.086 .017 .035** .033 .361 .446 
Night-to-night variability 
    
Sleep-onset latency .019 .594 .665 -.005 .893 .926 .076 .036 .067* -.026 .470 .556 
Sleep-onset time .122 7E-4 .005** .102 .004 .014** .113 .002 .010** .009 .813 .876 
Sleep-offset time .110 .002 .010** .119 9E-4 .006** .069 .057 .098 -.062 .087 .144 
Sleep duration .098 .006 .018** .092 .011 .025** .097 .007 .019** -.003 .931 .943 
NWAK .145 6E-5 9E-4** .109 .002 .010** .152 2E-5 7E-4** -.092 .011 .025** 
WASO .115 .001 .007** .116 .001 .007** .095 .008 .020** -.109 .002 .010** 
Sleep efficiency .106 .003 .011** .095 .008 .020** .103 .004 .014** -.092 .011 .025** 
PSQI (n = 1766)    
 
Sleep-onset latencya .013 .576 .660 .078 .001 .007** -.080 8E-4 .005** -.098 4E-5 8E-4** 
Bedtimea,b .029 .230 .333 .018 .444 .533 .041 .087 .144 .001 .968 .968 
Get-up timea -.022 .348 .439 -.023 .344 .439 -.020 .413 .502 -.013 .581 .660 
Sleep durationa -.038 .114 .177 -.095 7E-5 9E-4** .027 .261 .359 .081 6E-4 .005** 
Sleep efficiencyc .002 .925 .943 -.065 .006 .018** .071 .003 .011** .091 1E-4 .002** 
Daytime sleepinessa .075 .002 .010** .088 2E-4 .002** .052 .028 .057* -.086 3E-4 .003** 
PSQI scored .063 .008 .020** .158 3E-11 1E-9** -.063 .008 .020** -.165 3E-12 3E-10** 
Night-to-night variability is operationalized by intraindividual standard deviation (ISD) across a single subject's multiple nights. 
Note that Hypomanic Core, Social Vitality and Ordinariness here refer to factor scores derived from factor analyses. Results were 
additionally confirmed by analyses with traditional sum scores (see Supplementary Table 4). 
Effects of sex and age were partialled out. FDR: False Discovery Rate according to Benjamini and Hochberg11; NWAK: Number of 
awakenings; WASO: wake after sleep-onset time 
* p < .05 (two-sided nominal significance) 
** FDR < .05 (p value corrected for all tested associations applying the Benjamini-Hochberg FDR method11) 
a based on the respective PSQI item b time subject goes to bed; c quotient of sleep duration and time in bed with the latter calculated 
from bedtime and get-up time; d PSQI total score calculated according the manual from all PSQI components; higher PSQI scores 










Supplementary Table S3. Comparison of Spearman correlations 
 
  
Spearman’s rho  P value of Spearman’s rho comparisons 

















     
Means        
Sleep-onset latency .038 .042 .054 -.035 .831 .549 .211 .779 .180 .112 
Sleep-onset time -.006 -.035 .025 .061 .172 .258 .247 .153 .095 .512 
Sleep-offset time -.013 -.041 .007 .056 .181 .469 .235 .249 .091 .377 
Sleep duration -.079 -.072 -.059 .034 .750 .471 .054 .759 .068 .098 
NWAK .078 .069 .069 -.011 .667 .734 .125 .999 .165 .153 
WASO .103 .091 .080 -.046 .593 .399 .011** .782 .018* .025* 
Sleep efficiency -.106 -.101 -.086 .033 .797 .467 .017* .732 .021* .033* 
Night-to-night variability       
Sleep-onset latency .019 -.005 .076 -.026 .257 .038* .437 .054 .714 .070 
Sleep-onset time .122 .102 .113 .009 .357 .727 .051 .808 .104 .063 
Sleep-offset time .110 .119 .069 -.062 .680 .124 .003** .226 .002** .020* 
Sleep duration .098 .092 .097 -.003 .748 .963 .081 .894 .101 .074 
NWAK .145 .109 .152 -.092 .092 .787 5E-5** .301 5E-4** 1E-5** 
WASO .115 .116 .095 -.109 .963 .463 1E-4** .616 9E-5** 3E-4** 
Sleep efficiency .106 .095 .103 -.092 .599 .923 7E-4** .838 .001** 5E-4** 
PSQI (n = 1766)       
Sleep-onset latencya .013 .078 -.080 -.098 2E-6** 1E-7** .004** 5E-9** 4E-6** .624 
Bedtimea,b .029 .018 .041 .001 .450 .493 .470 .408 .653 .273 
Get-up timea -.022 -.023 -.020 -.013 .989 .872 .810 .911 .806 .860 
Sleep durationa -.038 -.095 .027 .081 3E-5** 3E-4** .002** 7E-6** 4E-6** .132 
Sleep efficiencyc .002 -.065 .071 .091 1E-6** 1E-4** .021* 6E-7** 5E-5** .586 
Daytime sleepinessa .075 .088 .052 -.086 .315 .202 3E-5** .181 5E-6** 1E-4** 










Comparisons of Spearman’s rho correlation coefficients was carried out according to the formula by Dunn & Clark12 as 
implemented in R package cocor v.1.1-313. 
HT HPS Total; HC Hypomanic Core; SV Social Vitality; OD Ordinariness 
* p < .05 (two-sided nominal significance) 
** FDR < .05 (p value corrected for all tested associations using Benjamini-Hochberg FDR method) 
Night-to-night variability is operationalized by intraindividual standard deviation (ISD) across a single subject's multiple nights. 
a based on the respective PSQI item b time subject goes to bed; c quotient of sleep duration and time in bed with the latter 
calculated from bedtime and get-up time; d PSQI total score calculated according the manual from all PSQI components; higher 







Secondary analyses for confirmation of results 
 
Further analyses were conducted to confirm the correlational results. First, all correlational analyses were 
repeated with unweighted sum scores for each HPS subscale instead of factor scores, which resulted in 
comparable, albeit, as expected, somewhat weaker associations (see Table S1). In total, 39 out of 84 
correlations reached the level of nominal significance. Of those, 32 remained significant after multiple-
testing correction. A reduction in the number of significant associations was most pronounced for the facet 
Ordinariness. 
 




HPS sum score  
Unweighted sum score 
of 
Hypomanic Core 
Unweighted sum score 
of 
Social Vitality 
 Unweighted sum score 
of 
Ordinariness 
 rho p FDR rho p FDR rho p FDR rho p FDR
Actigraphy (n = 771)       
Means       
Sleep-onset latency .038 .294 .419 .032 .372 .480 .056 .124 .200 -.013 .719 .784 
Sleep-onset time -.006 .864 .874 -.008 .816 .836 .044 .228 .339 .033 .356 .475 
Sleep-offset time -.013 .721 .784 -.024 .508 .611 .013 .728 .784 .045 .214 .326 
Sleep duration -.079 .029 .068* -.079 .029 .068 * -.063 .083 .151 .024 .509 .611 
NWAK .078 .030 .068* .063 .080 .150 .059 .101 .170 .027 .456 .563 
WASO .103 .004 .020** .085 .018 .047 ** .069 .056 .110 .009 .812 .836 
Sleep efficiency -.106 .003 .015** -.094 .009 .030 ** -.079 .029 .068* -.010 .775 .818 
Night-to-night 
variability 
      
Sleep-onset latency .019 .594 .674 -.010 .779 .818 .075 .038 .083* -.033 .366 .480 
Sleep-onset time .122 7E-4 .007** .098 .006 .025 ** .123 7E-4 .007** .077 .033 .073* 
Sleep-offset time .110 .002 .012** .125 5E-4 .007 ** .059 .100 .170 -.028 .436 .547 
Sleep duration .098 .006 .025** .087 .015 .043 ** .097 .007 .027** .061 .093 .167 
NWAK .145 6E-5 .002** .115 .001 .010 ** .145 6E-5 .002** -.022 .535 .633 
WASO .115 .001 .010** .107 .003 .015 ** .082 .024 .060* -.047 .193 .304 
Sleep efficiency .106 .003 .015** .090 .013 .037 ** .094 .009 .030** -.036 .315 .434 
PSQI (n = 1766)       
Sleep-onset 
latencya 
.013 .576 .663 .063 .008 .029 ** -.079 8E-4 .007** -.057 .017 .045** 
Bedtimea,b .029 .230 .339 .031 .196 .304 .046 .051 .105 .009 .699 .783 
Get-up timea -.022 .348 .471 -.025 .299 .419 -.019 .432 .547 -.013 .573 .663 
Sleep durationa -.038 .114 .187 -.088 2E-4 .004 ** .028 .236 .342 .040 .096 .168 
Sleep efficiencyc .002 .925 .925 -.046 .053 .105 .073 .002 .012** .046 .051 .105 
Daytime sleepinessa .075 .002 .012** .081 6E-4 .007 ** .061 .010 .031** -.042 .080 .150 
PSQI scored .063 .008 .029** .127 9E-8 7E-6 ** -.061 .011 .032** -.088 2E-4 .004** 
Effects of sex and age were partialled out. FDR: False Discovery Rate according to Benjamini and Hochberg11; NWAK: Number of 
awakenings; WASO: wake after sleep-onset time 
* p < .05 (two-sided nominal significance) 
** FDR < .05 (p value corrected for all tested associations applying the Benjamini-Hochberg FDR method11) 
Night-to-night variability is operationalized by intraindividual standard deviation (ISD) across a single subject's multiple nights. 
a based on the respective PSQI item b time subject goes to bed; c quotient of sleep duration and time in bed with the latter calculated 
from bedtime and get-up time; d PSQI total score calculated according the manual from all PSQI components; higher PSQI scores 







As another confirmation of results, analyses were repeated using HPS decile extreme groups (as is often done 
in psychometric high-risk studies). HPS extreme groups were defined as the lower (HPS-); and upper (HPS+) 
decile of the distribution (HPS- : n=61, range 0-2, mean sum score = 1.39, SD=0.74; HPS +: n=63, 
mean sum score = 20.23, SD = 3.79, range: 16-37).  
Results from extreme group comparisons are presented in Supplementary Table S5 and illustrated in 
Supplementary Figure S4. In total, 38 out of 84 comparisons reached the level of nominal significance, of 
which 23 remained significant after multiple-testing correction. Concerning objective sleep, HPS high-scorers 
had significantly lower sleep efficiency and more time WASO. In accordance with the correlational analyses, 
the extreme groups more   strongly differed concerning the night-to-night variability of sleep parameters than 
concerning the mean sleep parameters. The HPS high scorers showed greater variability in all sleep variables, 
except for of sleep-onset latency which did not reach significance level. Also in line with correlation analyses, 
HPS high-scorers had lower self-reported sleep efficiency, worse overall sleep quality (PSQI total score) and 

























































 Inference statistics 
HPS+ HPS- Mean ranksa χ² η² p FDR
N 63 61   
Demography   
Sex (f/m) 28 / 35 27 / 34  0.000 < 0.001 .984  
Age (yrs) 70.2 (4.1) 70.1 (4.2) 63.12 / 61.86 0.038 < 0.001 .845  
Actigraphy   
Means   
Sleep-onset latency (min) 0:09 (0:06) 0:07 (0:04) 68.13 / 56.69 3.140 0.025 .076 .140  
Sleep-onset time (h:min) 23:29 (0:51) 23:29 (0:49) 61.58 / 63.45 0.084 0.001 .772 .809  
Sleep-offset time (h:min) 7:00 (0:43) 7:04 (0:44) 62.06 / 62.96 0.020 < 0.001 .889 .889  
Sleep duration (h:min) 6:12 (1:15) 6:34 (0:53) 58.78 / 66.34 1.374 0.011 .241 .332  
NWAK 3.23 (1.2) 2.92 (1.2) 66.30 / 58.57 1.436 0.012 .231 .332  
WASO (h:min) 1:19 (0:39) 1:00 (0:29) 70.83 / 53.90 6.872 0.055 .009 .021 ** 
Sleep efficiency (%) 81.8 (6.3) 85.3 (6.2) 53.05 / 72.26 8.859 0.071 .003 .011 ** 
Night-to-night variability   
Sleep-onset latency (min) 0:07 (0:04) 0:06 (0:03) 65.84 / 59.05 1.107 0.009 .293 .379  
Sleep-onset time (h:min) 0:46 (0:24) 0:35 (0:19) 70.13 / 54.62 5.768 0.047 .016 .036 ** 
Sleep-offset time (h:min) 0:52 (0:35) 0:37 (0:18) 73.52 / 51.11 12.049 0.097 5E-4 .003 ** 
Sleep duration (h:min) 0:59 (0:20) 0:46 (0:18) 73.83 / 50.80 12.717 0.103 4E-4 .003 ** 
NWAK 1.62 (0.5) 1.29 (0.5) 74.49 / 50.11 14.267 0.115 2E-4 .003 ** 
WASO (h:min) 0:39 (0:21) 0:27 (0:14) 73.32 / 51.33 11.602 0.094 7E-4 .003 ** 
Sleep efficiency (%) 6.73 (2.6) 5.50 (2.2) 71.14 / 53.57 7.406 0.060 .006 .018 ** 
PSQI  
Sleep-onset latencyb 0:24 (0:26) 0:16 (0:14) 66.31 / 58.57 1.485 0.012 .223 .332  
Bedtimeb,c 23:00 (0:52) 22:52 (0:46) 65.34 / 59.57 0.841 0.007 .359 .439  
Get-up timeb 7:24 (0:45) 7:16 (0:42) 64.79 / 60.13 0.545 0.004 .460 .533  
Sleep durationb 6:51 (1:05) 7:09 (1:03) 57.54 / 67.62 2.714 0.022 .099 .168  
Sleep efficiencyd 82.1 (11.9) 85.5 (10.6) 56.60 / 68.60 3.475 0.028 .062 .125  
Daytime sleepinessb 0.30 (0.64) 0.07 (0.31) 67.77 / 57.06 7.722 0.062 .005 .017 ** 
PSQI scoree 5.87 (3.2) 3.92 (2.9) 74.05 / 50.57 13.444 0.108 2E-4 .003 ** 
 
Except for sex and n, descriptive statistics are presented as mean (standard deviation). Inference statistics are based on χ²-Test 
(sex), or Kruskal-Wallis Test (all other variables). All χ² values are specified by one degree of freedom. The effect size η² was 
calculated by squaring r derived from r=√(χ²/N) according to Rosenthal & DiMatteo14. FDR: False Discovery Rate according to 
Benjamini and Hochberg11 
* p < .05 (two-sided nominal significance) 
** FDR < .05 (p value corrected for all shown associations applying Benjamini-Hochberg FDR method11) 
Night-to-night variability is operationalized by intraindividual standard deviation (ISD) across a single subject's multiple nights. 
a Mean rank HPS+ / mean rank HPS- 
b based on the respective PSQI item c time subject goes to bed; d quotient of sleep duration and time in bed with the latter 
calculated from bedtime and get-up time; e PSQI total score calculated according the manual from all PSQI components; 




Supplementary Fig. S4. Boxplots of actigraphy and PSQI variables stratified by HPS extreme groups 
 
Intraindividual night-to-night variability is operationalized by intraindividual standard deviation (ISD) across a single subject's multiple 
nights. Boxplots are stratified by top and bottom decile HPS groups (HPS+, N=63 vs. HPS-, N=61). Boxes represent the interquartile 
range of each distribution (data between the lower and upper quartile), with the horizontal line corresponding to the median. Whiskers 
extend to the furthest observation within 1.5 times the interquartile range from the lower and upper quartile. Dots represent single data 





Exploratory regression analysis with HPS subscales 
In the present study, lowest type-I-error probabilities were obtained for associations between the PSQI total 
score (an indicator for poor sleep quality) and higher scores on the Hypomanic Core subscale (rho = .158, 
P = 3E-11), and lower scores on the Ordinariness subscale (rho = -.165, P = 3E-12). Although correlations 
with Social Vitality were weaker (rho = -.063, P = .008), an exploratory linear regression analysis with 
ranked variables (resembling Spearman correlations) revealed that all three subscales explained independent 
variance in PSQI total scores. In total, 6.0% of the variance in PSQI total scores (adjusted for sex and age) 
was explained by the weighted combination of Hypomanic Core (β = .161, P = 1.3E-10, ηp² = 0.023), 
Social Vitality (β = -.139, P = 8.6E-9, ηp² = 0.019), and Ordinariness (β = -.135, P = 1.7E-8, ηp² = 
0.018). The strength of this association was substantial when compared to using the HPS total score (HPS 
Total) as the regressor, which resulted in an explained variance of only 0.4% (ηp² = 0.004, P = .008). The 
observed failure of the HPS Total appeared to be attributable to the facet Social Vitality. Whereas the facet 
Hypomanic Core positively correlated with both HPS Total (rho = .832) and poor sleep quality and 
Ordinariness negatively correlated with both the HPS Total (rho = -.292) and poor sleep quality, Social 
Vitality correlated positively with HPS Total (rho = .721) but negatively with poor sleep quality. Hence, the 
multidimensional HPS scale differentially associates with subjective sleep quality, with associations of 
aggregated scales apparently cancelling each other out. To unravel the mechanisms between hypomanic 





Prediction of HPS by sleep and covariates 
To investigate the relative importance of objective and subjective sleep variables and covariates in predicting 
Hypomanic Personality Scores, we carried out a series of regression analyses. In order to avoid overfitting 
and inflated R2 estimates, we used a tenfold cross-validation approach which involves evaluating the 
performance of a prediction model by applying the model to new data not used in training it.  
We selected N = 640 subjects with valid data from both the actigraphy assessment and the PSQI 
questionnaire. From the set of 21 sleep variables, we dropped the actigraphy variable ‘mean sleep-offset 
time’ and the PSQI variable ‘sleep-efficiency’ due to reasons of multicollinearity (stepwise exclusion of 
variables with a variance inflation factor > 10). 
We sought to determine the incremental predictive value of sleep variables by comparing the performance of 
a full model to the performance of a standard covariate model. The standard covariate model contained the 
predictors sex, age, socioeconomic status (SES), body mass index (BMI), and questionnaire-derived indicators 
of sleep apnea and Periodic Limb Movement Disorder (PLMD). We selected these variables due to their 
extensive implications for sleep behavior and affective traits. Socioeconomic status was calculated as a 
combination of education, working status, and household income as previously described.15 Information on 
sleep apnea and PLMD were drawn from two PSQI items that were answered by the participant’s partner and 
were not aggregated to the PSQI total score (‘long pauses between breaths while asleep’, ‘legs twitching or 
jerking while asleep’). These two PSQI items were rated on a 4-point scale. Missing item responses (22% and 
20%, respectively) were substituted by the sample median. 
 
We analyzed the performance of three different full models. The first full model contained the actigraphy 
variables, while the second model contained the PSQI variables. The third full model included both the 
actigraphy and PSQI variables. All full models included the variables of the standard covariate model as 
described above. 
 
In order to carry out the tenfold cross-validation procedure, our sample was split into ten equal sized subsets. 
To ensure comparable distributions of HPS scores across the ten subsets, the sample was sorted according to 
the respective HPS score (total or subscale score) and subjects of the first, second, third, …, 64th decuplet 
were each randomly assigned to one of the ten subsets. Next, one of the subsets was selected as the testing 
dataset, while the other nine subsets served as the training dataset. After the first model was trained and 
tested, the next subset was selected as the testing sample, while the other nine subsets served as the training 
sample. This procedure was carried on until each subset served exactly once as the testing dataset. The 
tenfold cross-validation procedure with random group assignment was repeated 100 times so that 100 
predictions were made for each subject. Predicted HPS scores were then averaged and correlated with the 
measured HPS scores. 
 
Prediction models were built using the gradient boosting package ‘xgboost’ (v.0.82.1)16 in R. The xgboost 
algorithms have been widely used in the field of supervised machine learning and their solutions have been 
awarded in several data science competitions. We trained our models with the tree booster. The learning rate 
was set to eta = 0.02 with a maximum tree depth of 3. Training iterations were set to 1000. Of the nine 
training subsets, eight subsets served to fit the model, while one subset was selected to monitor model 
performance and avoid overfitting. The training process was stopped after 50 iterations if no further 
improvement was achieved. We used default settings for all other training parameters. 
 
Supplementary Table S6 shows the Pearson correlations between predicted and measured HPS scores for the 
standard covariate model and the three full models. ∆R2 reflects the increase in explained variance of a full 
model relative to the standard covariate model and was calculated as follows: 
∆R2 = rho2Full - rho
2
Standard 
Significance of ∆R2 was calculated by comparing the correlations of the full and standard model using the 













Supplementary Table S6. Pearson correlations between predicted and measured HPS scores 
 







 HPS subscale 
Ordinariness 
 rho p ∆R2 rho p ∆R2 rho p ∆R2 rho p ∆R2
Standard model .015 .696  -.002 .954  .166 2E-5  -.034 .388  
Full model acti .111 .005 0.012* .145 2E-4 0.021* .162 4E-5 -0.001 .087 .028 0.006* 
Full model PSQI .075 .057 0.005 .179 5E-6 0.032** .141 3E-4 -0.008 .066 .095 0.003* 
Full model acti + PSQI .135 .001 0.018* .246 3E-10 0.060** .157 7E-5 -0.003 .113 .004 0.012* 
Predicted HPS scores were derived from a tenfold cross-validation procedure with 100 repeats. Models were trained using R package 
xgboost with booster type ‘gbtree’. ∆R2 reflects the increase in R2 relative to the standard model. Significance of ∆R2 is indicated by asterisks 
and was calculated by comparing the correlations of the full and standard model using the formula by Dunn & Clark12 as implemented in R 
package cocor v.1.1-313. 
* p(∆R2) < .050 (two-sided nominal significance of ∆R2) 
** p(∆R2) < .001 (two-sided nominal significance of ∆R2) 
 
Overall, adding objective and subjective sleep variables as features to the machine learning model 
significantly increased accuracy in predicting HPS scores. The highest predictive accuracy was achieved for 
the HPS subscale Hypomanic Core, resulting in a Pearson correlation between predicted and measured 
scores of rho = .246 (p = 3E-10) and an incremental value of sleep variables of ∆R2 = 0.060 (p = 7E-7). 
Furthermore, there was an incremental value of sleep variables in predicting both the subscale Ordinariness 
(∆R2 = 0.012, p = .003) and the HPS total score (∆R2 = 0.018, p = .010). In comparison, although 
predicted scores of the HPS subscale Social Vitality significantly correlated with the measured scores (rho 
= .157, p = 7E-5), analyses did not reveal evidence for an incremental value of sleep variables (∆R2 = -
0.003, p = .784). In sum, our analyses revealed a predictive value of sleep variables for three of the four 
HPS scores, with the highest model performance observed for the subscale Hypomanic Core. 
 
Next, we extracted the relative contribution of each variable to the prediction models. We used the function 
‘xgb.importance’ in the R package xgboost and averaged the relative feature gain across all full models that 
included both the actigraphy and PSQI variables. Supplementary Figure S5 shows the relative contribution of 
each variable to the respective prediction model. 
 
 
Supplementary Fig. S5. Bar plot showing the relative importance of each variable to the prediction model 
 
 
The bar plot illustrates the relative contribution of each feature to the tree-based prediction models. Note that the importance metric 
allows comparing the role of variables within each model, but does not enable inferences on absolute magnitudes across models. This 
implies that the bar plot does not account for varying prediction performances. BMI: Body Mass Index; SES: socioeconomic status; cov: 
covariate; acti: sleep variable from actigraphy; psqi: sleep variable from questionnaire Pittsburgh Sleep Quality Index; NWAK: number 
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The current study analyses the associations of objective and subjective sleep parameters and day-
time sleepiness with a risk factor for bipolar disorder (BD), the Hypomanic Personality Scale (HPS). 
In a large cohort of healthy subjects, we expect associations between the HPS and shorter and 
more disturbed sleep, increased daytime sleepiness and more night-to-night sleep-variability. In 
contrast to most prior research, we did not only associate sleep with the HPS total score, but also 
with HPS subscales. To this end, we conducted the first factor analysis on the German translation of 
the HPS. We hypothesize that the associations of the HPS with sleep variables will differ with respect 
to the HPS subscales. 
 
Introduction: 
Sleep in Bipolar Disorder 
Sleep disturbances and increased daytime sleepiness occur in BD during manic episodes, but also 
in the euthymic state1,2. Accumulating data suggests that impaired or reduced sleep and increased 
daytime sleepiness are not only symptoms of BD, but contribute to the disease process itself and to 
manic and hypomanic behavior in particular3-9. Experimental and longitudinal studies of patients, 




Further, in a recent study10 daytime sleepiness predicted manic and hypomanic relapse. Present 
findings on impaired sleep in euthymic BD leave it unclear to what extent these disturbances are a 
predisposition, a consequence of the disease process or due to medication. Studying healthy sub-
jects who are vulnerable to BD can improve our understanding of whether sleep impairment is a 
predisposing factor. Genetic high-risk studies have mostly shown that sleep in healthy offspring of 
BD patients is indeed impaired11–13. There is only one longitudinal study, which was not based on 
genetic high-risk offspring but on a healthy community sample, and which could nonetheless pre-
dict subsequent development of BD during a ten-year follow up by poor sleep quality at baseline14. 
Moreover, this prediction of BD by poor sleep persisted when excluding subjects with a family histo-
ry of affective disorders. Lack of data and a low probability of incident BD in healthy subjects not 
genetically at risk are inherent problems of such longitudinal cohort studies. Thus, more data are 
needed.  
 
The Hypomanic Personality Scale 
The psychometric high-risk approach15, which assesses e.g. BD risk in large populations via ques-
tionnaires such as the Hypomanic Personality Scale16, is one useful method to detect vulnerable 
subjects. The HPS as a dimensional scale allows not only for the identification of unusually high 
scorers (high risk subjects), but also the assessment of the total normal variance. The association of 
the entire continuum of bipolarity with sleep disturbances can then be examined. The HPS assesses 
features of hypomanic episodes as described within the diagnostic systems, but also includes corre-
lated traits such as social dominance. As the scale assesses a temperamental dimension, i.e. a 
personality trait rather than an acute episode, subjects are instructed to respond how they feel in 
general. Several studies have demonstrated the scale’s reliability and validity. The HPS is stable 
over time16,17, has been associated with psychiatric risk genes18,19, aggregates in families of afflict-
ed patients20 and has discriminated bipolar patients from controls21,22. Cross-sectionally, HPS high 
scorers showed higher rates of (hypo)manic and depressed episodes and more psychosocial im-
pairment and substance use16,23,24. Longitudinally, the HPS predicted BD and hypomanic symptoms 
in addition to related disorders such as substance abuse25–27.   
However, it has recently been suggested that the HPS should be separated into different subscales 
which may have divergent psychopathological correlates28-30.  
 
Sleep in Hypomanic Personality  
To date, only two small studies using student samples have assessed the association between sleep 
and HPS. In HPS high scorers, greater intraindividual variability in sleep duration was observed via 
sleep diaries31 and actigraphy32. The latter study32 also showed shorter sleep duration and greater 




studies utilized the HPS total sum score. In two recent studies28,30, HPS subscales were derived from 




The study sample was drawn from the LIFE-Adult study34, a population-based cohort comprised of 
10,000 inhabitants of the city of Leipzig, Germany. Of the total sample, participants aged 60–82 
years completed the HPS. Subjects had to be free of diseases or medications which could strongly 
impact sleep–wake behavior. Subjects were excluded when at current use of CNS-affecting drugs. 
Based on data from structured clinical interviews for DSM-IV Axis I disorders, we selected subjects 
without a lifetime history of substance dependence, psychotic or BDs, and who were free of current 
affective or anxiety disorders. In addition, participants were required to have available data from 
either the Pittsburgh sleep quality index (PSQI) assessment or an actigraphy recording for at least 
five nights. This resulted in a final sample of 771 subjects for actigraphy association analyses (372 
female, Mage = 70.3 y), and 1766 subjects for PSQI association analyses (835 female, Mage = 
69.6 y). Factor analyses of the HPS were conducted using all 2861 subjects with complete HPS 
responses (1371 female; age range: 60–82 years; Mage = 70.0).  
 
Sleep Data 
To obtain objective measurements of sleep, subjects wore the SenseWear Pro 3 Armband acti-
graph for an average of 6.9 days (range: 5–7 days). Subjective ratings of sleep and sleep quality 
were obtained using the German version of the PSQI35, a self-rating instrument to assess sleep 
quality during the past 4 weeks.  
 
The Hypomanic Personality Scale 
The HPS, a self-rating scale used to assess BD risk25, was developed with young subjects, which is 
reflected in some of the 48 items. As the current study applied the HPS to elderly subjects, four 
items from the German translation36 were deleted for reasons of compliance. 
Associations between the sleep variables and the HPS were conducted for both the HPS total sum 
score (HPS total) and factor scores for each HPS subscale. We conducted partial Spearman corre-
lations adjusting for sex and age.  
 
Results: 
The factor analysis of the HPS revealed three factors, which we labeled “hypomanic core”, “social 
vitality” and “ordinariness”. Spearman correlations (Table 1) showed, that HPS total scale was cor-
related with significantly shorter sleep duration, a greater number of awakenings, more time after 




night-to-night variability of the sleep parameters. On subscale level, sleep-wake variables were 
also significantly associated in the same direction with hypomanic core.  In subjective sleep data 
(see PSQI data in Table 1), HPS total correlated with more daytime sleepiness and lower sleep 
quality, which was even stronger on subscale level in hypomanic core, which was also associated 
with longer latency of sleep-onset, short sleep duration, lower sleep efficiency and more daytime 




Partial Spearman correlations between hypomanic personality and sleep-wake variables 
 







 HPS subscale 
Ordinariness 
 rho p  rho p rho p rho p 
Actigraphy (n = 771)     
Means     
Sleep-onset latency .038 .294 .042 .240 .054 .134 -.035 .329 
Sleep-onset time -.006 .864 -.035 .329 .025 .497 .061 .089 
Sleep-offset time -.013 .721 -.041 .252 .007 .851 .056 .118 
Sleep duration -.079 .029* -.072 .046* -.059 .101 .034 .350 
NWAK .078 .030* .069 .056 .069 .056 -.011 .757 
WASO .103 .004** .091 .011* .080 .027* -.046 .203 
Sleep efficiency -.106 .003** -.101 .005** -.086 .017* .033 .361 
Night-to-night variability      
Sleep-onset latency .019 .594 -.005 .893 .076 .036* -.026 .470 
Sleep-onset time .122 7E-4** .102 .004** .113 .002** .009 .813 
Sleep-offset time .110 .002** .119 9E-4** .069 .057 -.062 .087 
Sleep duration .098 .006** .092 .011* .097 .007** -.003 .931 
NWAK .145 6E-5** .109 .002** .152 2E-5** -.092 .011** 
WASO .115 .001** .116 .001** .095 .008** -.109 .002** 
Sleep efficiency .106 .003** .095 .008** .103 .004** -.092 .011** 
PSQI (n = 1766)     
Sleep-onset latency
a
 .013 .576 .078 .001** -.080 8E-4** -.098 4E-5** 
Bedtime
a,b
 .029 .230 .018 .444 .041 .087 .001 .968 
Get-up time
a
 -.022 .348 -.023 .344 -.020 .413 -.013 .581 
Sleep duration
a
 -.038 .114 -.095 7E-5** .027 .261 .081 6E-4** 
Sleep efficiency
c
 .002 .925 -.065 .006** .071 .003** .091 1E-4** 
Daytime sleepiness
a
 .075 .002** .088 2E-4** .052 .028* -.086 3E-4** 
PSQI score
d
 .063 .008** .158 3E-11** -.063 .008** -.165 3E-12** 
Night-to-night variability is operationalized by intraindividual standard deviation (ISD) across a single subject's multiple nights. 
Note that Hypomanic Core, Social Vitality and Ordinariness here refer to factor scores derived from factor analyses as described in the 
Methods of the Supplementum. Results were additionally confirmed by analyses with traditional sum scores (see section 3.3). 
Effects of sex and age were partialled out. *p < .05, **p < .01; NWAK: Number of awakenings; WASO: wake after sleep-onset time;  
a 
based on the respective Pittsburgh Sleep Quality Index (PSQI) item
 b
 time subject goes to bed; 
c 
quotient of sleep duration and time in 
bed with the latter calculated from bedtime and get-up time; 
d
 PSQI total score calculated according the manual from all PSQI 






The current study analyzed whether increased vulnerability to BD, as assessed by the HPS, is linked 
to more disturbed sleep in healthy subjects. Correlation analyses were conducted between 
objective as well as subjective sleep parameters and HPS subscales and total scale. The correlation 
analyses as well as the extreme group comparisons revealed that a higher HPS total score is 
associated with worse sleep, greater night-to-night sleep variability and more daytime sleepiness. 
Thus, results confirm findings of impaired sleep in genetic high risk studies12. A noteworthy finding 
is that the HPS was more strongly associated with the night-to-night variability than with the mean 
sleep variables. In line with this, irregularity in sleep/wake behavior has been reported for euthymic 
and manic patients2,37 and subjects with genetically or psychometrically operationalized heightened 
BD risk2,12,31,32,38,39. Another finding is, that the HPS subscale hypomanic core correlations with 
impaired sleep variables were significantly higher than of HPS total. In contrast, the subscales 
ordinariness and social vitality showed associations with better perceived sleep. Thus, the current 
study strongly supports the suggestion of utilizing HPS subscales28-30, 33. The high scored daytime 
sleepiness given in subjective data and long sleep-onset latencies may occur due to being overly 
excited and reluctanct to fall asleep. The associations with shorter sleep are in line with studies 
conducted on young HPS high scorers and children at genetic risk for BD32,40. This stands in 
contrast to findings of longer sleep in euthymic BD1,2. This might imply that long sleep may not be 
a preexisting factor, but instead part of the disease or a consequence of sedating medications, 
unemployement or psychotherapeutical interventions for longer sleep to avoid mania. 
 
Strenghts and limitations: 
Our subscales’ correlations with sleep variables need replication in other, particularly younger 
samples. We showed that the HPS is also applicable in subjects older than 60 years. The older age 
of our sample supports our aim to associate the vulnerability factor HPS with sleep, as our subjects 
are unlikely to develop BD in the future. The present study was well-powered and revealed strong 
evidence for a link between hypomanic temperament and sleep alterations even though the effect 
sizes were small in correlation analyses.  
 
Conclusion: 
The assiciations of the HPS with worse sleep and higher inter-night variability were consistent and 
especially HPS subscales support the suggestion of the HPS as a diagnostic and vulnerability factor. 
It supports the suggestion that impaired sleep may be a predisposing factor for BD. Interventions in 
improving sleep in HPS high scorers may be a valuable, modifiable and easy to access early 
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